Thursday 9 June 2022
12:30–14:00 (CEST)
Advancing patient care in CF: Where next? 
Chair: Harm Tiddens (NL)
12:30 - 12:32Introductory animation
12:32 – 12:42

Chair’s intro: CF management: Looking back to think ahead

  • Q&A
Harm Tiddens
Erasmus MC (NL)
12:42 - 12:57

CF today and tomorrow: Following the disease course 

  • Q&A
Peter Barry,
Manchester University NHS Foundation Trust (UK)
12:57 - 13:12

Adherence in CF: What do we know?

  • Q&A
Alexandra Quittner
Behavioral Health Systems Research (US)
13:12 - 13:27

Patient outcomes: What counts and can be counted? 

  • Q&A
Barry Plant
Cork University Hospital (IE)
13:27 - 13:57Panel discussion and Q&A – a multidisciplinary perspectiveAll speakers plus Chris Smith, Brighton and
Sussex University Hospitals (UK) and
Inge Heeres, Erasmus MC (NL)
13.57 - 14:00Chair’s close of symposiumHarm Tiddens
Erasmus MC (NL)

Thursday 9 June 2022
19:00–20:30 (CEST)
Inhaled antibiotics in cystic fibrosis: Still a standard of care in the new normal?
Chairs: Stuart Elborn (UK) / Stephanie Thee (DE)
SpeakersProfessor J. Stuart Elborn, clinician, UK (co-chair) 
Dr. Stephanie Thee, clinician, DE (co-chair)
Dr. Simone Gambazza, physiotherapist, IT
Cora de Kiviet, nurse, NL

An interactive on-stage discussion featuring multiple perspectives within cystic fibrosis

  • Defining the "new normal" for inhaled antibiotics within cystic fibrosis as part of an evolving treatment landscape
  • The treatment expectations placed on antibiotics and how these may be managed
  • The challenges that patients with cystic fibrosis, nurses, physiotherapists and doctors face
    ​​​​​​​and different approaches to overcome them
  • How patient health may be optimised and maintained through a hybrid treatment approach

Friday 10 June 2022
12:30–14:00 (CEST)
Continuing the journey of innovation for all people with CF
Chair: Stuart Elborn (UK)
12:30 - 12:32Introductory animation
12:32 – 12:50 Chair’s intro: Where are we now? Past learnings and future perspectivesStuart Elborn, 
Queen’s University (UK)
12:50 – 13:15A path for all people living with CF? Looking back to think aheadFred Van Goor,  Head of Cystic Fibrosis Research,
Vertex Pharmaceuticals (US)
13:15 - 13:55Panel discussion: what is the next scientific frontier in the treatment of people with CF? 

Stuart Elborn (UK) and Fred Van Goor (US)
plus Nicoletta Pedemonte, Giannina Gaslini Institute (IT) and Patrick Harrison, University College Cork (IE)
13:55 – 14:00Chair’s close of symposium Stuart Elborn, 
Queen’s University (UK)